BXCL701
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BXCL701, covering 2025-07-18 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]